The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Non-invasive prenatal DNA testing is a new generation of prenatal testing technology that uses next-generation high-throughput sequencing to detect fetal chromosomal abnormalities.
Global Non-invasive DNA Prenatal Testing market is projected to reach US$ 10400 million in 2029, increasing from US$ 4703 million in 2022, with the CAGR of 12.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Non-invasive DNA Prenatal Testing market research.
Key companies engaged in the Non-invasive DNA Prenatal Testing industry include Illumina, Roche, Natera, Thermo Fisher Scientific, F. Hoffman-La Roche, Pacific Biosciences Of California, Perkinelmer, LifeCodexx and Agilent Technologies, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Non-invasive DNA Prenatal Testing were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Non-invasive DNA Prenatal Testing market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Non-invasive DNA Prenatal Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- Illumina
- Roche
- Natera
- Thermo Fisher Scientific
- F. Hoffman-La Roche
- Pacific Biosciences Of California
- Perkinelmer
- LifeCodexx
- Agilent Technologies
- Labcorp
- Mutiplicon
- Premaitha Health
- Beijing BGI
- Berry Genomics
- Darui Biological
Segment by Type
- Equipment
- Consumables
Segment by Application
- Hospital
- Clinic
- Other
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
- Latin America (Mexico, Brazil, Rest of Latin America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
The Non-invasive DNA Prenatal Testing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-invasive DNA Prenatal Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Equipment
1.2.3 Consumables
1.3 Market by Application
1.3.1 Global Non-invasive DNA Prenatal Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-invasive DNA Prenatal Testing Market Perspective (2018-2029)
2.2 Non-invasive DNA Prenatal Testing Growth Trends by Region
2.2.1 Global Non-invasive DNA Prenatal Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Non-invasive DNA Prenatal Testing Historic Market Size by Region (2018-2023)
2.2.3 Non-invasive DNA Prenatal Testing Forecasted Market Size by Region (2024-2029)
2.3 Non-invasive DNA Prenatal Testing Market Dynamics
2.3.1 Non-invasive DNA Prenatal Testing Industry Trends
2.3.2 Non-invasive DNA Prenatal Testing Market Drivers
2.3.3 Non-invasive DNA Prenatal Testing Market Challenges
2.3.4 Non-invasive DNA Prenatal Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-invasive DNA Prenatal Testing Players by Revenue
3.1.1 Global Top Non-invasive DNA Prenatal Testing Players by Revenue (2018-2023)
3.1.2 Global Non-invasive DNA Prenatal Testing Revenue Market Share by Players (2018-2023)
3.2 Global Non-invasive DNA Prenatal Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-invasive DNA Prenatal Testing Revenue
3.4 Global Non-invasive DNA Prenatal Testing Market Concentration Ratio
3.4.1 Global Non-invasive DNA Prenatal Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-invasive DNA Prenatal Testing Revenue in 2022
3.5 Non-invasive DNA Prenatal Testing Key Players Head office and Area Served
3.6 Key Players Non-invasive DNA Prenatal Testing Product Solution and Service
3.7 Date of Enter into Non-invasive DNA Prenatal Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-invasive DNA Prenatal Testing Breakdown Data by Type
4.1 Global Non-invasive DNA Prenatal Testing Historic Market Size by Type (2018-2023)
4.2 Global Non-invasive DNA Prenatal Testing Forecasted Market Size by Type (2024-2029)
5 Non-invasive DNA Prenatal Testing Breakdown Data by Application
5.1 Global Non-invasive DNA Prenatal Testing Historic Market Size by Application (2018-2023)
5.2 Global Non-invasive DNA Prenatal Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Non-invasive DNA Prenatal Testing Market Size (2018-2029)
6.2 North America Non-invasive DNA Prenatal Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Non-invasive DNA Prenatal Testing Market Size by Country (2018-2023)
6.4 North America Non-invasive DNA Prenatal Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-invasive DNA Prenatal Testing Market Size (2018-2029)
7.2 Europe Non-invasive DNA Prenatal Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Non-invasive DNA Prenatal Testing Market Size by Country (2018-2023)
7.4 Europe Non-invasive DNA Prenatal Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-invasive DNA Prenatal Testing Market Size (2018-2029)
8.2 Asia-Pacific Non-invasive DNA Prenatal Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Non-invasive DNA Prenatal Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Non-invasive DNA Prenatal Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-invasive DNA Prenatal Testing Market Size (2018-2029)
9.2 Latin America Non-invasive DNA Prenatal Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Non-invasive DNA Prenatal Testing Market Size by Country (2018-2023)
9.4 Latin America Non-invasive DNA Prenatal Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size (2018-2029)
10.2 Middle East & Africa Non-invasive DNA Prenatal Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Non-invasive DNA Prenatal Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Non-invasive DNA Prenatal Testing Introduction
11.1.4 Illumina Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)
11.1.5 Illumina Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Non-invasive DNA Prenatal Testing Introduction
11.2.4 Roche Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Natera
11.3.1 Natera Company Detail
11.3.2 Natera Business Overview
11.3.3 Natera Non-invasive DNA Prenatal Testing Introduction
11.3.4 Natera Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)
11.3.5 Natera Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Non-invasive DNA Prenatal Testing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 F. Hoffman-La Roche
11.5.1 F. Hoffman-La Roche Company Detail
11.5.2 F. Hoffman-La Roche Business Overview
11.5.3 F. Hoffman-La Roche Non-invasive DNA Prenatal Testing Introduction
11.5.4 F. Hoffman-La Roche Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)
11.5.5 F. Hoffman-La Roche Recent Development
11.6 Pacific Biosciences Of California
11.6.1 Pacific Biosciences Of California Company Detail
11.6.2 Pacific Biosciences Of California Business Overview
11.6.3 Pacific Biosciences Of California Non-invasive DNA Prenatal Testing Introduction
11.6.4 Pacific Biosciences Of California Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)
11.6.5 Pacific Biosciences Of California Recent Development
11.7 Perkinelmer
11.7.1 Perkinelmer Company Detail
11.7.2 Perkinelmer Business Overview
11.7.3 Perkinelmer Non-invasive DNA Prenatal Testing Introduction
11.7.4 Perkinelmer Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)
11.7.5 Perkinelmer Recent Development
11.8 LifeCodexx
11.8.1 LifeCodexx Company Detail
11.8.2 LifeCodexx Business Overview
11.8.3 LifeCodexx Non-invasive DNA Prenatal Testing Introduction
11.8.4 LifeCodexx Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)
11.8.5 LifeCodexx Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Detail
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Non-invasive DNA Prenatal Testing Introduction
11.9.4 Agilent Technologies Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)
11.9.5 Agilent Technologies Recent Development
11.10 Labcorp
11.10.1 Labcorp Company Detail
11.10.2 Labcorp Business Overview
11.10.3 Labcorp Non-invasive DNA Prenatal Testing Introduction
11.10.4 Labcorp Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)
11.10.5 Labcorp Recent Development
11.11 Mutiplicon
11.11.1 Mutiplicon Company Detail
11.11.2 Mutiplicon Business Overview
11.11.3 Mutiplicon Non-invasive DNA Prenatal Testing Introduction
11.11.4 Mutiplicon Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)
11.11.5 Mutiplicon Recent Development
11.12 Premaitha Health
11.12.1 Premaitha Health Company Detail
11.12.2 Premaitha Health Business Overview
11.12.3 Premaitha Health Non-invasive DNA Prenatal Testing Introduction
11.12.4 Premaitha Health Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)
11.12.5 Premaitha Health Recent Development
11.13 Beijing BGI
11.13.1 Beijing BGI Company Detail
11.13.2 Beijing BGI Business Overview
11.13.3 Beijing BGI Non-invasive DNA Prenatal Testing Introduction
11.13.4 Beijing BGI Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)
11.13.5 Beijing BGI Recent Development
11.14 Berry Genomics
11.14.1 Berry Genomics Company Detail
11.14.2 Berry Genomics Business Overview
11.14.3 Berry Genomics Non-invasive DNA Prenatal Testing Introduction
11.14.4 Berry Genomics Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)
11.14.5 Berry Genomics Recent Development
11.15 Darui Biological
11.15.1 Darui Biological Company Detail
11.15.2 Darui Biological Business Overview
11.15.3 Darui Biological Non-invasive DNA Prenatal Testing Introduction
11.15.4 Darui Biological Revenue in Non-invasive DNA Prenatal Testing Business (2018-2023)
11.15.5 Darui Biological Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
